| HOME >> MEDICINE >> TECHNOLOGY |
Innovative Medicines Initiative [EU]
Itochu Chemical Frontier
Janssen Pharmaceutica (a subsidiary of J&J)
Japan Patent Office (JPO)
Johnson & Johnson (J&J)
Kyorin Pharmaceutical
Lupin
Massachusetts Biologic Laboratories
Mayne Pharma
Medarex (part of Bristol-Myers Squibb)
Medicines and Healthcare Products Regulatory Agency (MHRA) [UK]
Medicis
Medison Pharma
Meiji Holdings (parent company of Meiji Seika Pharma)
Meiji Seika Pharma
Merck & Co.
MerLion Pharmaceuticals
Ministry of Health, Labor and Welfare (MHLW)
Mylan
Mylan Seiyaku (a subsidiary of Mylan)
Nabriva Therapeutics
Nanotherapeutics
National Institute of Allergy and Infectious Diseases (NIAID) [US]
Nektar Therapeutics
Nestlé
NeuTec Pharma (part of Novartis, now closed)
Nichi-Iko Pharmaceutical
Nipro Pharma
Novartis
Novexel (part of AstraZeneca)
Optimer Biotechnology (a subsidiary of Optimer)
Optimer Pharmaceuticals
Ortho-McNeil Pharmaceutical (a subsidiary of J&J)
Paratek Pharmaceuticals
Patent and Trademark Office [US]
Peninsula Pharmaceuticals (part of J&J)
Pfizer
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmacia (part of Pfizer)
Pliva (part of Teva)
Proctor & Gamble (P&G)
Protez Pharmaceuticals (part of Novartis, now closed)
Ranbaxy (part of Daiichi Sankyo)
Rib-X Pharmaceuticals
Roche
Rutgers University [US]
Salix Pharmaceuticals
Sandoz (a division of Novartis)
Sanofi
Sawai Pharmaceutical
Schering-Plough (part of Merck & Co)
Scottish Medicines Consortium (SMC)
Senju Pharmaceutical
Sequella
Shantou Meiji Pharmaceuticals (a subsidiary of Meiji Seika Pharma)
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |